PEPGEN

Serial Number 78797060
606

Registration Progress

Application Filed
Jan 23, 2006
Under Examination
Dec 5, 2006
Approved for Publication
Aug 23, 2006
Published for Opposition
Sep 12, 2006
Registered

Trademark Image

PEPGEN

Basic Information

Serial Number
78797060
Filing Date
January 23, 2006
Published for Opposition
September 12, 2006
Abandonment Date
December 6, 2007
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 6, 2007
Classes
005

Rights Holder

Pepgen Corporation

03
Address
1255 Harbor Bay Parkway Suite B
Alameda, CA 94502

Ownership History

Pepgen Corporation

Original Applicant
03
Alameda, CA

Pepgen Corporation

Owner at Publication
03
Alameda, CA

Legal Representation

Attorney
Brian R. Coleman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Jan 8, 2008 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 20, 2007 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 29, 2007 EX1G S EXTENSION 1 GRANTED Loading...
Jun 14, 2007 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jun 14, 2007 PETG O PETITION TO REVIVE-GRANTED Loading...
Jun 14, 2007 TPEX I EXTENSION RECEIVED WITH TEAS PETITION Loading...
Jun 5, 2007 EXT1 S EXTENSION 1 FILED Loading...
Dec 5, 2006 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 12, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 23, 2006 NPUB O NOTICE OF PUBLICATION Loading...
Jul 26, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 21, 2006 ALIE A ASSIGNED TO LIE Loading...
Jul 19, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 12, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 27, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM Loading...

Detailed Classifications

Class 005
Biopharmaceuticals for use in the diagnosis, prevention, and treatment of human and animal diseases, namely cancer, viral infections, microbial infections, autoimmune diseases, allergies, immunological dysfunctions, neurological disorders, blood disorders, and inflammatory diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005